Menu
GeneBe

rs151325573

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_000534.5(PMS1):c.1609G>A(p.Glu537Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00243 in 1,607,300 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0021 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0025 ( 6 hom. )

Consequence

PMS1
NM_000534.5 missense

Scores

7
7

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: 3.85
Variant links:
Genes affected
PMS1 (HGNC:9121): (PMS1 homolog 1, mismatch repair system component) This gene encodes a protein belonging to the DNA mismatch repair mutL/hexB family. This protein is thought to be involved in the repair of DNA mismatches, and it can form heterodimers with MLH1, a known DNA mismatch repair protein. Mutations in this gene cause hereditary nonpolyposis colorectal cancer type 3 (HNPCC3) either alone or in combination with mutations in other genes involved in the HNPCC phenotype, which is also known as Lynch syndrome. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0070312917).
BP6
Variant 2-189854881-G-A is Benign according to our data. Variant chr2-189854881-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 135055.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome at 3 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PMS1NM_000534.5 linkuse as main transcriptc.1609G>A p.Glu537Lys missense_variant 9/13 ENST00000441310.7
LOC105373796XR_001739151.2 linkuse as main transcriptn.319-2024C>T intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PMS1ENST00000441310.7 linkuse as main transcriptc.1609G>A p.Glu537Lys missense_variant 9/131 NM_000534.5 P1P54277-1

Frequencies

GnomAD3 genomes
AF:
0.00207
AC:
314
AN:
152020
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000749
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00282
Gnomad ASJ
AF:
0.00952
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000944
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00293
Gnomad OTH
AF:
0.00336
GnomAD3 exomes
AF:
0.00219
AC:
546
AN:
249024
Hom.:
3
AF XY:
0.00224
AC XY:
302
AN XY:
135038
show subpopulations
Gnomad AFR exome
AF:
0.000513
Gnomad AMR exome
AF:
0.00297
Gnomad ASJ exome
AF:
0.00988
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000197
Gnomad FIN exome
AF:
0.0000463
Gnomad NFE exome
AF:
0.00280
Gnomad OTH exome
AF:
0.00248
GnomAD4 exome
AF:
0.00247
AC:
3591
AN:
1455162
Hom.:
6
Cov.:
29
AF XY:
0.00244
AC XY:
1764
AN XY:
724140
show subpopulations
Gnomad4 AFR exome
AF:
0.000542
Gnomad4 AMR exome
AF:
0.00344
Gnomad4 ASJ exome
AF:
0.0114
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000186
Gnomad4 FIN exome
AF:
0.000169
Gnomad4 NFE exome
AF:
0.00266
Gnomad4 OTH exome
AF:
0.00224
GnomAD4 genome
AF:
0.00206
AC:
313
AN:
152138
Hom.:
1
Cov.:
32
AF XY:
0.00194
AC XY:
144
AN XY:
74382
show subpopulations
Gnomad4 AFR
AF:
0.000747
Gnomad4 AMR
AF:
0.00282
Gnomad4 ASJ
AF:
0.00952
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000944
Gnomad4 NFE
AF:
0.00291
Gnomad4 OTH
AF:
0.00332
Alfa
AF:
0.00294
Hom.:
2
Bravo
AF:
0.00214
TwinsUK
AF:
0.00324
AC:
12
ALSPAC
AF:
0.00311
AC:
12
ESP6500AA
AF:
0.000455
AC:
2
ESP6500EA
AF:
0.00443
AC:
38
ExAC
AF:
0.00188
AC:
228
EpiCase
AF:
0.00289
EpiControl
AF:
0.00356

ClinVar

Significance: Likely benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1Other:1
Likely benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoJul 27, 2021- -
not provided, no classification providedreference populationITMISep 19, 2013- -
not provided Benign:1
Likely benign, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-The PMS1 p.Glu361Lys variant was not identified in the literature nor was it identified in Cosmic or LOVD 3.0. The variant was identified in dbSNP (ID: rs151325573) and ClinVar (classified as a VUS by Illumina and Genomic Research Center, Shahid Beheshti University of Medical Sciences for Lynch Syndrome). The variant was identified in control databases in 596 of 280400 chromosomes (3 homozygous) at a frequency of 0.002126 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: Ashkenazi Jewish in 101 of 10314 chromosomes (freq: 0.009793), Latino in 103 of 35214 chromosomes (freq: 0.002925), European (non-Finnish) in 354 of 128070 chromosomes (freq: 0.002764), Other in 18 of 7128 chromosomes (freq: 0.002525), African in 13 of 24308 chromosomes (freq: 0.000535), South Asian in 6 of 30404 chromosomes (freq: 0.000197) and European (Finnish) in 1 of 25054 chromosomes (freq: 0.00004); it was not observed in the East Asian population. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. The p.Glu361 residue is not conserved in mammals and four out of five computational analyses (SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. -
Hereditary breast ovarian cancer syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingGenomic Research Center, Shahid Beheshti University of Medical SciencesMay 03, 2020- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.11
T
BayesDel_noAF
Uncertain
0.070
Cadd
Benign
19
Dann
Uncertain
1.0
DEOGEN2
Benign
0.016
T;T;T;T;T;.;.;.;.
Eigen
Uncertain
0.25
Eigen_PC
Uncertain
0.23
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.92
D;.;D;D;D;D;D;D;D
M_CAP
Benign
0.066
D
MetaRNN
Benign
0.0070
T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.48
D
MutationTaster
Benign
0.95
D;D;D;D;D;D
PrimateAI
Benign
0.35
T
Polyphen
0.93, 0.89
.;.;.;P;P;.;.;.;.
Vest4
0.27, 0.27, 0.32, 0.30, 0.34, 0.29
MVP
0.99
MPC
0.16
ClinPred
0.039
T
GERP RS
5.0
Varity_R
0.073
gMVP
0.28

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs151325573; hg19: chr2-190719607; COSMIC: COSV59717585; COSMIC: COSV59717585; API